Ligand validation:5M8T

0TR: 2-HYDROXYCYCLOHEPTA-2,4,6-TRIEN-1-ONE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5M8T_0TR_B_517	40%	6%	0.167	0.877	2.32	2.85	2	2	1	0	100%	1
5M8T_0TR_D_518	37%	8%	0.239	0.938	2.33	2.3	3	2	1	0	100%	0.82
5M8T_0TR_A_513	33%	4%	0.187	0.867	2.64	2.91	4	3	4	0	100%	1
5M8T_0TR_C_516	12%	4%	0.269	0.8	2.52	3	2	2	3	0	100%	1
5M8O_0TR_A_512	76%	9%	0.13	0.967	2.49	2.02	2	2	1	0	100%	1
5THJ_0TR_A_302	59%	37%	0.141	0.924	1.02	1.44	1	1	0	0	100%	1
5THI_0TR_A_302	36%	17%	0.182	0.874	1.14	2.42	1	3	4	0	100%	0.9
2Y9X_0TR_B_410	24%	58%	0.241	0.872	1.08	0.54	1	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.